Retraction: Metalloprotease cleavage of the N terminus of the orphan G protein-coupled receptor GPR37L1 reduces its constitutive activity (Science Signaling (2016) 9 (ra36) DOI: 10.1126/scisignal.aad1089);Metalloprotease cleavage of the N terminus of the orphan G protein-coupled receptor GPR37L1 reduces its constitutive activity

Science Signaling

Volumn 9, Issue 423, 2016, Pages

  Coleman, James L J ^a,b   Ngo, Tony ^a,b   Schmidt, Johannes ^a   Mrad, Nadine ^a   Liew, Chu Kong ^a   Jones, Nicole M ^b   Graham, Robert M ^a,b   Smith, Nicola J ^a,b  

^a VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; ADAM10 ENDOPEPTIDASE; ADAM12 PROTEIN; ADAM17 PROTEIN; ADAM28 PROTEIN; ADAM33 PROTEIN; BATIMASTAT; BETA GALACTOSIDASE; CYCLIC AMP; DOXYCYCLINE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 37L1; GELATINASE A; ISOBUTYLMETHYLXANTHINE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 16; MATRIX METALLOPROTEINASE 19; MATRIX METALLOPROTEINASE 24; METALLOPROTEINASE; PEPTIDE; PEPTIDE TX14A; SIGNAL PEPTIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 4; UNCLASSIFIED DRUG; YELLOW FLUORESCENT PROTEIN; GPR37L1 PROTEIN, HUMAN; MUTANT PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; BIOTINYLATION; CELL SURFACE; CEREBELLAR SLICE; CEREBELLUM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DEGLYCOSYLATION; EMBRYO; ENZYME ACTIVE SITE; GLYCOSYLATION; HEK293 CELL LINE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CLEAVAGE; PROTEIN FUNCTION; RAT; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION; WESTERN BLOTTING; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; FEMALE; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM; PROTEIN DEGRADATION; SEQUENCE HOMOLOGY; SPRAGUE DAWLEY RAT;

ADAM PROTEINS; AMINO ACID SEQUENCE; ANIMALS; FEMALE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HEK293 CELLS; HUMANS; IMMUNOBLOTTING; MALE; METALLOPROTEASES; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; MUTANT PROTEINS; PROTEOLYSIS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION;

EID: 84963742269     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.aba2063     Document Type: Erratum

References (59)

1. V. Katritch, V. Cherezov, R. C. Stevens, Structure-function of the G protein-coupled receptor superfamily. Annu. Rev. Pharmacol. Toxicol. 53, 531-556 (2013).
2. D. K. Vassilatis, J. G. Hohmann, H. Zeng, F. Li, J. E. Ranchalis, M. T. Mortrud, A. Brown, S. S. Rodriguez, J. R. Weller, A. C. Wright, J. E. Bergmann, G. A. Gaitanaris, The G protein-coupled receptor repertoires of human and mouse. Proc. Natl. Acad. Sci. U.S.A. 100, 4903-4908 (2003).
3. X.-L. Tang, Y. Wang, D.-L. Li, J. Luo, M.-Y. Liu, Orphan G protein-coupled receptors (GPCRs): Biological functions and potential drug targets. Acta Pharmacol. Sin. 33, 363-371 (2012).
4. D. M. Rosenbaum, S. G. Rasmussen, B. K. Kobilka, The structure and function of Gprotein-coupled receptors. Nature 459, 356-363 (2009).
5. G. Milligan, Constitutive activity and inverse agonists of G protein-coupled receptors: A current perspective. Mol. Pharmacol. 64, 1271-1276 (2003).
6. N. J. Smith, L. M. Luttrell, Signal switching, crosstalk, and arrestin scaffolds: Novel G protein-coupled receptor signaling in cardiovascular disease. Hypertension 48, 173-179 (2006).
7. D. Marazziti, C. Di Pietro, E. Golini, S. Mandillo, G. La Sala, R. Matteoni, G. P. Tocchini-Valentini, Precocious cerebellum development and improved motor functions in mice lacking the astrocyte cilium-, patched 1-associated GPR37L1 receptor. Proc. Natl. Acad. Sci. U.S.A. 110, 16486-16491 (2013).
8. N. Leng, G. Gu, R. B. Simerly, E. R. Spindel, Molecular cloning and characterization of two putative G protein-coupled receptors which are highly expressed in the central nervous system. Brain Res. Mol. Brain Res. 69, 73-83 (1999).
9. O. Valdenaire, T. Giller, V. Breu, A. Ardati, A. Schweizer, J. G. Richards, A new family of orphan G protein-coupled receptors predominantly expressed in the brain. FEBS Lett. 424, 193-196 (1998).
10. N. J. Smith, Drug discovery opportunities at the endothelin B receptor-related orphan G protein-coupled receptors, GPR37 and GPR37L1. Front. Pharmacol. 6, 275 (2015).
11. R. C. Meyer, M. M. Giddens, S. A. Schaefer, R. A. Hall, GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin. Proc. Natl. Acad. Sci. U.S.A. 110, 9529-9534 (2013).
12. S. E. Schutzer, T. Liu, B. H. Natelson, T. E. Angel, A. A. Schepmoes, S. O. Purvine, K. K. Hixson, M. S. Lipton, D. G. Camp II, P. K. Coyle, R. D. Smith, J. Bergquist, Establishing the proteome of normal human cerebrospinal fluid. PLOS One 5, e10980 (2010).
13. M. Stark, O. Danielsson, W. J. Griffiths, H. Jörnvall, J. Johansson, Peptide repertoire of human cerebrospinal fluid: Novel proteolytic fragments of neuroendocrine proteins. J. Chromatogr. B Biomed. Sci. Appl. 754, 357-367 (2001).
14. X. Zhao, K. Southwick, H. L. Cardasis, Y. Du, M. E. Lassman, D. Xie, M. El-Sherbeini, W. M. Geissler, K. D. Pryor, A. Verras, M. Garcia-Calvo, D.-M. Shen, N. A. Yates, S. Pinto, R. C. Hendrickon, Peptidomic profiling of human cerebrospinal fluid identifies YPRPIHPA as a novel substrate for prolylcarboxypeptidase. Proteomics 10, 2882-2886 (2010).
15. G. S. Cottrell, Roles of proteolysis in regulation of GPCR function. Br. J. Pharmacol. 168, 576-590 (2013).
16. L. Jenkins, J. Brea, N. J. Smith, B. D. Hudson, G. Reilly, N. J. Bryant, M. Castro, M. I. Loza, G. Milligan, Identification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of β-arrestin-2 and activate Gα13. Biochem. J. 432, 451-459 (2010).
17. J. Schmidt, N. J. Smith, E. Christiansen, I. G. Tikhonova, M. Grundmann, B. D. Hudson, R. J. Ward, C. Drewke, G. Milligan, E. Kostenis, T. Ulven, Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: Identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3. J. Biol. Chem. 286, 10628-10640 (2011).
18. N. J. Smith, L. A. Stoddart, N. M. Devine, L. Jenkins, G. Milligan, The action and mode of binding of thiazolidinedione ligands at free fatty acid receptor 1. J. Biol. Chem. 284, 17527-17539 (2009).
19. N. J. Smith, R. J. Ward, L. A. Stoddart, B. D. Hudson, E. Kostenis, T. Ulven, J. C. Morris, C. Tränkle, I. G. Tikhonova, D. R. Adams, G. Milligan, Extracellular loop 2 of the free fatty acid receptor 2 mediates allosterism of a phenylacetamide ago-allosteric modulator. Mol. Pharmacol. 80, 163-173 (2011).
20. L. A. Stoddart, N. J. Smith, L. Jenkins, A. J. Brown, G. Milligan, Conserved polar residues in transmembrane domains V, VI, and VII of free fatty acid receptor 2 and free fatty acid receptor 3 are required for the binding and function of short chain fatty acids. J. Biol. Chem. 283, 32913-32924 (2008).
21. N. J. Smith, Low affinity GPCRs for metabolic intermediates: Challenges for pharmacologists. Front. Endocrin. 3, 1 (2012).
22. C. Rutz, W. Klein, R. Schulein, N-terminal signal peptides of G protein-coupled receptors: Significance for receptor biosynthesis, trafficking, and signal transduction. Prog. Mol. Biol. Transl. Sci. 132, 267-287 (2015).
23. A. Boire, L. Covic, A. Agarwal, S. Jacques, S. Sherifi, A. Kuliopulos, PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120, 303-313 (2005).
24. E. Grantcharova, J. Furkert, H. P. Reusch, H. W. Krell, G. Papsdorf, M. Beyermann, R. Schulein, W. Rosenthal, A. Oksche, The extracellular N terminus of the endothelin B (ETB) receptor is cleaved by a metalloprotease in an agonist-dependent process. J. Biol. Chem. 277, 43933-43941 (2002).
25. A. E. Hakalahti, M. M. Vierimaa, M. K. Lilja, E. P. Kumpula, J. T. Tuusa, U. E. Petäjä-Repo, Human b1-adrenergic receptor is subject to constitutive and regulated N-terminal cleavage. J. Biol. Chem. 285, 28850-28861 (2010).
26. K. Brew, H. Nagase, The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity. Biochim. Biophys. Acta 1803, 55-71 (2010).
27. J. Arribas, L. Coodly, P. Vollmer, T. K. Kishimoto, S. Rose-John, J. Massagué, Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J. Biol. Chem. 271, 11376-11382 (1996).
28. K. Reiss, P. Saftig, The "a disintegrin and metalloprotease" (ADAM) family of sheddases: Physiological and cellular functions. Semin. Cell Dev. Biol. 20, 126-137 (2009).
29. S. J. Dowell, A. J. Brown, Yeast assays for G protein-coupled receptors. Methods Mol. Biol. 552, 213-229 (2009).
30. T. Ngo, J. L. Coleman, N. J. Smith, Using constitutive activity to define appropriate high-throughput screening assays for orphan G protein-coupled receptors. Methods Mol. Biol. 1272, 91-106 (2015).
31. F. Giannone, G. Malpeli, V. Lisi, S. Grasso, P. Shukla, D. Ramarli, S. Sartoris, V. Monsurró, M. Krampera, E. Amato, G. Tridente, M. Colombatti, M. Parenti, G. Innamorati, The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis. J. Mol. Endocrinol. 44, 259-269 (2010).
32. E. Kostenis, M. Waelbroeck, G. Milligan, Techniques: Promiscuous Gα proteins in basic research and drug discovery. Trends Pharmacol. Sci. 26, 595-602 (2005).
33. Z. Cheng, D. Garvin, A. Paguio, P. Stecha, K. Wood, F. Fan, Luciferase reporter assay system for deciphering GPCR pathways. Curr. Chem. Genomics 4, 84-91 (2010).
34. E. G. Lundius, V. Vukojevic, E. Hertz, N. Stroth, A. Cederlund, M. Hiraiwa, L. Terenius, P. Svenningsson, GPR37 protein trafficking to the plasma membrane regulated by prosaposin and GM1 gangliosides promotes cell viability. J. Biol. Chem. 289, 4660-4673 (2014).
35. K.-D. Min, M. Asakura, Y. Liao, K. Nakamaru, H. Okazaki, T. Takahashi, K. Fujimoto, S. Ito, A. Takahashi, H. Asanuma, S. Yamazaki, T. Minamino, S. Sanada, O. Seguchi, A. Nakano, Y. Ando, T. Otsuka, H. Furukawa, T. Isomura, S. Takashima, N. Mochizuki, M. Kitakaze, Identification of genes related to heart failure using global gene expression profiling of human failing myocardium. Biochem. Biophys. Res. Commun. 393, 55-60 (2010).
36. S. R. Coughlin, Thrombin signalling and protease-activated receptors. Nature 407, 258-264 (2000).
37. D. L. Mann, R. L. Kent, B. Parsons, G. Cooper IV, Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 85, 790-804 (1992).
38. T. M. Wilkie, P. A. Scherle, M. P. Strathmann, V. Z. Slepak, M. I. Simon, Characterization of G-protein a subunits in the Gq class: Expression in murine tissues and in stromal and hematopoietic cell lines. Proc. Natl. Acad. Sci. U.S.A. 88, 10049-10053 (1991).
39. A. J. Brown, S. M. Goldsworthy, A. A. Barnes, M. M. Eilert, L. Tcheang, D. Daniels, A. I. Muir, M. J. Wigglesworth, I. Kinghorn, N. J. Fraser, N. B. Pike, J. C. Strum, K. M. Steplewski, P. R. Murdock, J. C. Holder, F. H. Marshall, P. G. Szekeres, S. Wilson, D. M. Ignar, S. M. Foord, A. Wiset, S. J. Dowell, The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278, 11312-11319 (2003).
40. C. Southern, J. M. Cook, Z. Neetoo-Isseljee, D. L. Taylor, C. A. Kettleborough, A. Merritt, D. L. Bassoni, W. J. Raab, E. Quinn, T. S. Wehrman, A. P. Davenport, A. J. Brown, A. Green, M. J. Wigglesworth, S. Rees, Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors. J. Biomol. Screen. 18, 599-609 (2013).
41. T. Kenakin, New concepts in pharmacological efficacy at 7TM receptors: IUPHAR review 2. Br. J. Pharmacol. 168, 554-575 (2013).
42. I. Liebscher, J. Schön, S. C. Petersen, L. Fischer, N. Auerbach, L. M. Demberg, A. Mogha, M. Cöster, K.-U. Simon, S. Rothemund, K. R. Monk, T. Schöneberg, A tethered agonist within the ectodomain activates the adhesion G protein-coupled receptors GPR126 and GPR133. Cell Rep. 9, 2018-2026 (2014).
43. H. M. Stoveken, A. G. Hajduczok, L. Xu, G. G. Tall, Adhesion G protein-coupled receptors are activated by exposure of a cryptic tethered agonist. Proc. Natl. Acad. Sci. U.S.A. 112, 6194-6199 (2015).
44. L. M. Demberg, S. Rothermund, T. Schöneberg, I. Liebscher, Identification of the tethered peptide agonist of the adhesion G protein-coupled receptor GPR64/ADGRG2. Biochem. Biophys. Res. Commun. 464, 743-747 2015.
45. B. A. Ersoy, L. Pardo, S. Zhang, D. A. Thompson, G. Millhauser, C. Govaerts, C. Vaisse, Mechanism of N-terminal modulation of activity at the melanocortin-4 receptor GPCR. Nat. Chem. Biol. 8, 725-730 (2012).
46. D. Lu, D. Willard, I. R. Patel, S. Kadwell, L. Overton, T. Kost, M. Luther, W. Chen, R. P. Woychik, W. O. Wilkison, R. D. Cone, Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 371, 799-802 (1994).
47. C. Haskell-Luevano, E. K. Monck, Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor. Regul. Pept. 99, 1-7 (2001).
48. P. Wei, Y.-G. Zhao, L. Zhuang, S. Ruben, Q.-X. A. Sang, Expression and enzymatic activity of human disintegrin and metalloproteinase ADAM19/meltrin βb. Biochem. Biophys. Res. Commun. 280, 744-755 (2001).
49. D. R. Edwards, M. M. Handsley, C. J. Pennington, The ADAM metalloproteinases. Mol. Aspects Med. 29, 258-289 (2008).
50. K. Kurohara, K. Komatsu, T. Kurisaki, A. Masuda, N. Irie, M. Asano, K. Sudo, Y.-I. Nabeshima, Y. Iwakura, A. Sehara-Fujisawa, Essential roles of Meltrin β (ADAM19) in heart development. Dev. Biol. 267, 14-28 (2004).
51. K. Horiuchi, H.-M. Zhou, K. Kelly, K. Manova, C. P. Blobel, Evaluation of the contributions of ADAMs 9, 12, 15, 17, and 19 to heart development and ectodomain shedding of neuregulins b1 and b2. Dev. Biol. 283, 459-471 (2005).
52. A. Tocchi, W. C. Parks, Functional interactions between matrix metalloproteinases and glycosaminoglycans. FEBS J. 280, 2332-2341 (2013).
53. B. I. Ratnikov, P. Cieplak, K. Gramatikoff, J. Pierce, A. Eroshkin, Y. Igarashi, M. Kazanov, Q. Sun, A. Godzik, A. Osterman, B. Stec, A. Strongin, J. W. Smith, Basis for substrate recognition and distinction by matrix metalloproteinases. Proc. Natl. Acad. Sci. U.S.A. 111, E4148-E4155 (2014).
54. E. Hadler-Olsen, B. Fadnes, I. Sylte, L. Uhlin-Hansen, J.-O. Winberg, Regulation of matrix metalloproteinase activity in health and disease. FEBS J. 278, 28-45 (2011).
55. O. Civelli, Y. Saito, Z. Wang, H.-P. Nothacker, R. K. Reinsheid, Orphan GPCRs and their ligands. Pharmacol. Ther. 110, 525-532 (2006).
56. J. H. Dunham, R. C. Meyer, E. L. Garcia, R. A. Hall, GPR37 surface expression enhancement via N-terminal truncation or protein-protein interactions. Biochemistry 48, 10286-10297 (2009).
57. H. Cimarosti, R. D. O'Shea, N. M. Jones, A. P. Horn, F. Simão, L. L. Zamin, M. Nassif, R. Frozza, C. A. Netto, P. M. Beart, C. Salbego, The effects of estradiol on estrogen receptor and glutamate transporter expression in organotypic hippocampal cultures exposed to oxygen-glucose deprivation. Neurochem. Res. 31, 483-490 (2006).
58. L. Stoppini, P.-A. Buchs, D. Muller, A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods 37, 173-182 (1991).
59. M. Canals, J. F. Lopez-Gimenez, G. Milligan, Cell surface delivery and structural re-organization by pharmacological chaperones of an oligomerization-defective a1b-adrenoceptor mutant demonstrates membrane targeting of GPCR oligomers. Biochem. J. 417, 161-172 (2009).